1. 639PVolume reduction rate of the primary tumor of esophageal squamous cell carcinoma after neoadjuvant chemotherapy: Could this measurement be a surrogate end point for survival before surgery?. (23rd October 2018) Authors: Nagasawa, S; Ogata, T; Hara, K; Shimoda, Y; Nakazono, M; Kumazu, Y; Hayashi, T; Yamada, T; Rino, Y; Masuda, M; Yoshikawa, T; Oshima, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 657PCan preoperative diagnosis select therapeutic target of neoadjuvant chemotherapy for gastric cancer?. (23rd October 2018) Authors: Hara, K; Hayashi, T; Shimoda, Y; Nakazono, M; Nagasawa, S; Kumazu, Y; Yamada, T; Rino, Y; Masuda, M; Ogata, T; Oshima, T; Yoshikawa, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 692PThe difference of risk factor for gastric cancer surgery between elderly and non-elderly patients. (23rd October 2018) Authors: Hayashi, T; Oshima, T; Hara, K; Shimoda, Y; Nakazono, M; Nagasawa, S; Kumazu, Y; Yamada, T; Rino, Y; Masuda, M; Ogata, T; Yoshikawa, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗